Calendar

The backtest reveals NVO experiences mixed outcomes after earnings misses, showing positive short-term returns of 1.12% at 3 days and 5.44% at 10 days, but a sharp decline of -4.60% at 30 days. Meanwhile, the Pharmaceuticals Industry overall shows negligible reaction, with returns close to zero over 49 days, indicating sector resilience to such events. This suggests that while NVO may offer short-term trading opportunities following earnings misses, the broader industry remains largely unaffected. Investors should approach NVO with caution for longer holds after misses, possibly favoring short-term strategies, whereas sector-wide moves appear limited.